Efficacy and Acceptance of Cognitive Behavioral Therapy in Adults with Chronic Fatigue Syndrome: A Meta-analysis.
Maas Genannt Bermpohl, Frederic, Kucharczyk-Bodenburg, Ann-Cathrin, Martin, Alexandra · International journal of behavioral medicine · 2024 · DOI
Quick Summary
This review analyzed 15 studies involving over 2,000 people with ME/CFS who received cognitive behavioral therapy (CBT)—a talk therapy that helps change thinking patterns and behavior. The results show that CBT helped reduce fatigue, depression, and anxiety compared to control groups, with benefits lasting at least several months after treatment ended. Most people who started CBT stayed in the program and completed their sessions, suggesting the treatment is acceptable to patients.
Why It Matters
This updated meta-analysis provides robust evidence that CBT produces measurable improvements in core ME/CFS symptoms and is well-tolerated by patients, helping clinicians and patients make informed decisions about treatment. The emphasis on treatment acceptability (drop-out rates) addresses a critical gap in previous research and demonstrates that CBT is not only effective but also sustainable for most people who undertake it.
Observed Findings
CBT reduced fatigue compared to controls with moderate effect size (g = -0.52)
Treatment benefits for fatigue and anxiety persisted at long-term follow-up
Drop-out rates were relatively low: 15% study drop-out, 22% non-completion of sessions, 7% treatment refusal
Total therapy duration moderated effects on fatigue; session number moderated effects on perceived health
Higher baseline fatigue severity was associated with improved treatment adherence
Inferred Conclusions
CBT is effective for reducing fatigue and mood symptoms in adults with CFS
CBT demonstrates high treatment acceptability with most patients completing the intervention
Therapeutic dosage (total time and session number) influences treatment efficacy, suggesting personalized intensity may optimize outcomes
Early evidence supports CBT as a viable clinical option, though maintenance of effects beyond measured follow-up periods requires further investigation
Remaining Questions
How long do CBT benefits persist beyond the longest follow-up periods measured in these trials?
What This Study Does Not Prove
This meta-analysis does not establish that CBT works equally well for all ME/CFS subtypes or severity levels, nor does it prove CBT addresses underlying biological mechanisms of the condition. The study cannot determine whether observed improvements result from specific therapeutic components or non-specific factors like attention and support. Long-term follow-up data beyond post-treatment remain limited, so durability beyond measured intervals is unclear.